Taurine Alleviates the Progression of Diabetic Nephropathy in Type 2 Diabetic Rat Model

Figure 6

Changes in 24 hours urinary MDA levels at 45 weeks of age. In the diabetic control group, MDA increased compared to the normal control group. MDA decreased in the taurine-treatment group compared to the diabetic control group. However, there was no statistical significance in this difference. MDA, malondialdehyde; LETO, normal control group; OLETF, diabetic control group; OLETF + TA, taurine-treated diabetic group.